Blair William & CO Neurocrine Biosciences Inc Transaction History

Blair William & CO

$36.3 Billion
Q3 2025

A detailed history of Blair William & CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Blair William & CO holds 4,461 shares of NBIX stock, worth $646,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,461

Previous 4,664 4.35%

Holding current value

$646,220

Previous $586,000 6.83%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$123.98 - $146.67 $25,167 - $29,774	-203 Reduced 4.35%	4,461 $626,000
Q2 2025 Jul 24, 2025	SELL	$87.54 - $128.18 $135,687 - $198,679	-1,550 Reduced 24.94%	4,664 $586,000
Q1 2025 May 09, 2025	SELL	$107.22 - $153.29 $25,947 - $37,096	-242 Reduced 3.75%	6,214 $687,000
Q4 2024 Feb 12, 2025	BUY	$111.62 - $139.44 $1,339 - $1,673	12 Added 0.19%	6,456 $881,000
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $158,464 - $211,806	-1,383 Reduced 17.67%	6,444 $741,000

Q2 2024 Aug 12, 2024	SELL	$130.86 - $143.19 $101,023 - $110,542	-772 Reduced 8.98%	7,827 $1.08 Million
Q1 2024 May 09, 2024	BUY	$130.4 - $143.74 $62,722 - $69,138	481 Added 5.93%	8,599 $1.19 Million
Q4 2023 Feb 12, 2024	SELL	$106.07 - $132.76 $59,611 - $74,611	-562 Reduced 6.47%	8,118 $1.07 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $525,101 - $654,003	-5,585 Reduced 39.15%	8,680 $976,000
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $26.6 Million - $31.2 Million	-297,485 Reduced 95.42%	14,265 $1.35 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $22.3 Million - $29.2 Million	237,264 Added 318.54%	311,750 $31.6 Million
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $6.74 Million - $8.03 Million	63,184 Added 559.05%	74,486 $8.9 Million
Q3 2022 Nov 09, 2022	BUY	$92.03 - $107.81 $15,645 - $18,327	170 Added 1.53%	11,302 $1.2 Million
Q2 2022 Aug 10, 2022	BUY	$75.79 - $100.07 $45,625 - $60,242	602 Added 5.72%	11,132 $1.09 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $348,267 - $455,751	-4,807 Reduced 31.34%	10,530 $987,000
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $377,541 - $503,482	-4,740 Reduced 23.61%	15,337 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $13,961 - $16,042	162 Added 0.81%	20,077 $1.93 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $22,178 - $25,362	248 Added 1.26%	19,915 $1.94 Million
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $924,914 - $1.26 Million	-10,562 Reduced 34.94%	19,667 $1.91 Million
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $2.63 Million - $3.27 Million	30,229 New	30,229 $2.9 Million

Others Institutions Holding NBIX

# of Institutions

726

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account